lymphoblastic Archives

lymphoblastic

FDA approved first gene therapy in U.S.

August 30, 2017

“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” said FDA Commissioner Scott Gottlieb, M.D.…

$relapsed or refractory acute lymphoblastic leukemia$

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

August 22, 2017

On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia…

FDA approved first gene therapy in U.S.

“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” said FDA…

$relapsed or refractory acute lymphoblastic leukemia$

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

lymphoblastic

FDA approved first gene therapy in U.S.

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

FDA approved first gene therapy in U.S.

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Reader Survey

Poll

About

Contact

Podcasts

American Nurse Journal

FDA approved first gene therapy in U.S.

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

lymphoblastic

FDA approved first gene therapy in U.S.

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

FDA approved first gene therapy in U.S.

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Reader Survey

Poll

NurseLine Newsletter

About

Contact

Podcasts

<img class="rss-widget-icon" style="border:0" width="14" height="14" src="https://www.myamericannurse.com/wp-includes/images/rss.png" alt="RSS" /> American Nurse Journal

FDA approved first gene therapy in U.S.

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

American Nurse Journal